# Combined Treatment for Generalized Anxiety Disorder (GAD)

> **NCT00620776** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 69 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **BEHAVIORAL:** Cognitive Behavioral Therapy
- **DRUG:** Venlafaxine XR

## Key facts

- **NCT ID:** NCT00620776
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2017-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620776, "Combined Treatment for Generalized Anxiety Disorder (GAD)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00620776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*